NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors von Wang-Gillam, Andrea, Hubner, Richard A., Siveke, Jens T., Von Hoff, Daniel D., Belanger, Bruce, de Jong, Floris A., Mirakhur, Beloo, Chen, Li-Tzong

Volltext

Combination Therapy with Immune Checkpoint Inhibitors and Histone Deacetylase Inhibitors or Alkylating Agents von Joerger, Markus, Koster, Kira-Lee, Janik, Tomas, de Jong, Floris A

Volltext

The role of cancer nurses in cancer-related pain management in Europe von de Munter, Johan, Dodlek, Nikolina, Khmaladze, Ani, Parreira, Sara Torcato, Ullgren, Helena, de Man, Rik, de Jong, Floris A., Oldenmenger, Wendy H.

Volltext

A Long-term Prospective Population Pharmacokinetic Study on Imatinib Plasma Concentrations in GIST Patients von EECHOUTE, Karel, FRANSSON, Martin N, LOOS, Walter J, MATHIJSSEN, Ron H. J, DE GIORGI, Ugo, REYNERS, An K, DE JONG, Floris A, SPARREBOOML, Alex, VAN DER GRAAF, Winette T. A, FRIBERG, Lena E, SCHIAVON, Gaia, WIEMER, Erik A. C, VERWEIJ, Jaap

Volltext

Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer von Chen, Li-Tzong, Macarulla, Teresa, Blanc, Jean-Frédéric, Mirakhur, Beloo, Jong, Floris A de, Belanger, Bruce, Bekaii-Saab, Tanios, Siveke, Jens T

Volltext

Complementary and Alternative Medicine During Cancer Treatment: Beyond Innocence von Tascilar, Metin, de Jong, Floris A., Verweij, Jaap, Mathijssen, Ron H. J.

Volltext

Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours von Mahalingam, Devalingam, Patel, Manish R., Sachdev, Jasgit C., Hart, Lowell L., Halama, Niels, Ramanathan, Ramesh K., Sarantopoulos, John, Völkel, Dirk, Youssef, Ashraf, Jong, Floris A., Tsimberidou, Apostolia Maria

Volltext

A CYP3A4 Phenotype–Based Dosing Algorithm for Individualized Treatment of Irinotecan von van der Bol, Jessica M, Mathijssen, Ron H J, Creemers, Geert-Jan M, Planting, André S Th, Loos, Walter J, Wiemer, Erik A C, Friberg, Lena E, Verweij, Jaap, Sparreboom, Alex, de Jong, Floris A

Volltext

Cigarette Smoking and Irinotecan Treatment: Pharmacokinetic Interaction and Effects on Neutropenia von VAN DER BOL, Jessica M, MATHIJSSEN, Ron H. J, LOOS, Walter J, FRIBERG, Lena E, VAN SCHAIK, Ron H. N, DE JONGE, Maja J. A, PLANTING, André S. Th, VERWEIJ, Jaap, SPARREBOOM, Alex, DE JONG, Floris A

Volltext

Role of pharmacogenetics in irinotecan therapy von de Jong, Floris A., de Jonge, Maja J.A., Verweij, Jaap, Mathijssen, Ron H.J.

Volltext

Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin von Hubner, Richard A., Cubillo, Antonio, Blanc, Jean-Frédéric, Melisi, Davide, Von Hoff, Daniel D., Wang-Gillam, Andrea, Chen, Li-Tzong, Becker, Claus, Mamlouk, Khalid, Belanger, Bruce, Yang, Yoojung, de Jong, Floris A., Siveke, Jens T.

Volltext

Management of fatigue in patients with cancer – A practical overview von Koornstra, Rutger H.T, Peters, Marlies, Donofrio, Stacey, van den Borne, Ben, de Jong, Floris A

Volltext

Early dose reduction/delay and the efficacy of liposomal irinotecan with fluorouracil and leucovorin in metastatic pancreatic ductal adenocarcinoma (mPDAC): A post hoc analysis of... von Chen, Li-Tzong, Macarulla, Teresa, Blanc, Jean-Frédéric, Mirakhur, Beloo, de Jong, Floris A., Belanger, Bruce, Bekaii-Saab, Tanios, Siveke, Jens T.

Volltext

Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: E... von Chen, Li-Tzong, Siveke, Jens T., Wang-Gillam, Andrea, Li, Chung-Pin, Bodoky, György, Dean, Andrew P., Shan, Yan-Shen, Jameson, Gayle S., Macarulla, Teresa, Lee, Kyung-Hun, Cunningham, David, Blanc, Jean-Frédéric, Chiu, Chang-Fang, Schwartsmann, Gilberto, Braiteh, Fadi S., Mamlouk, Khalid, Belanger, Bruce, de Jong, Floris A., Hubner, Richard A.

Volltext

Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST an... von Pelzer, Uwe, Blanc, Jean-Frédéric, Melisi, Davide, Cubillo, Antonio, Von Hoff, Daniel D, Wang-Gillam, Andrea, Chen, Li-Tzong, Siveke, Jens T, Wan, Yin, Solem, Caitlyn T, Botteman, Marc F, Yang, Yoojung, de Jong, Floris A, Hubner, Richard A

Volltext

Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: A prospective cross-over drug–drug interaction study von van der Bol, Jessica M, Loos, Walter J, de Jong, Floris A, van Meerten, Esther, Konings, Inge R.H.M, Lam, Mei H, de Bruijn, Peter, Wiemer, Erik A.C, Verweij, Jaap, Mathijssen, Ron H.J

Volltext

Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer – A subgroup analysis of the pivotal NAPOLI-1 trial von Macarulla, Teresa, Blanc, Jean-Frédéric, Wang-Gillam, Andrea, Chen, Li-Tzong, Siveke, Jens T., Mirakhur, Beloo, Chen, Jie, de Jong, Floris A.

Volltext

Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literature von Hamberg, Paul, De Jong, Floris A., Brandsma, Dieta, Verweij, Jaap, Sleijfer, Stefan

Volltext

Post-gemcitabine therapy for patients with advanced pancreatic cancer – a comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens von Vogel, Arndt, Ciardiello, Fortunato, Hubner, Richard A, Blanc, Jean-Frédéric, Carrato, Alfredo, Yang, Yoojung, Patel, Dipen A, Ektare, Varun, de Jong, Floris A, Gill, Sharlene

Volltext

ABCG2 pharmacogenetics: Ethnic differences in allele frequency and assessment of influence on irinotecan disposition von DE JONG, Floris A, MARSH, Sharon, MATHIJSSEN, Ron H. J, KING, Cristi, VERWEIJ, Jaap, SPARREBOOM, Alex, MCLEOD, Howard L

Volltext